PCV42 BUDGET IMPACT ANALYSIS OF INCORPORATING CRYO-BALLON CRYOABLATION FOR TREATMENT OF ATRIAL FIBRILLATION IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

Value in Health ◽

10.1016/j.jval.2020.04.147 ◽

2020 ◽

Vol 23 ◽

pp. S98

Author(s):

S. Borghossian ◽

F.A. Fujii ◽

P. Moretti

Keyword(s):

Atrial Fibrillation ◽

Healthcare System ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Private Healthcare

Download Full-text

PCN106 Cost-Minimization and Budget Impact Analysis of Venetoclax plus Obinutuzumab Versus Ibrutinib in Patients with Untreated Chronic Lymphocytic Leukemia in the Brazilian Private Healthcare System

Value in Health ◽

10.1016/j.jval.2021.04.198 ◽

2021 ◽

Vol 24 ◽

pp. S39

Author(s):

F.M. Vieira ◽

G.N. Ribeiro ◽

Filho C Brito ◽

A. Travassos

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Healthcare System ◽

Impact Analysis ◽

Budget Impact ◽

Cost Minimization ◽

Budget Impact Analysis ◽

Lymphocytic Leukemia ◽

Private Healthcare

Download Full-text

PIH23 BUDGET IMPACT ANALYSIS OF SFLT-1/PLGF RATIO TO HELP RULE-OUT PRE-ECLAPMSIA IN WOMEN PRESENTING WITH SUSPECTED PRE-ECLAMPSIA IN THE PRIVATE HEALTHCARE SYSTEM IN BRAZIL

Value in Health ◽

10.1016/j.jval.2019.04.823 ◽

2019 ◽

Vol 22 ◽

pp. S186

Author(s):

R. Ho ◽

M.M. Sebastião ◽

A. Vassalli ◽

M. D'Innocenzo ◽

M. Nussbaum

Keyword(s):

Healthcare System ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Private Healthcare ◽

Download Full-text

Budget Impact Analysis Of Adopting Evolocumab In The Brazilian Private Healthcare System For Patients With Uncontrolled LDL-C And High Cardiovascular Risk

Value in Health ◽

10.1016/j.jval.2017.08.2838 ◽

2017 ◽

Vol 20 (9) ◽

pp. A914-A915

Author(s):

RF dos Santos ◽

FP Alves ◽

M Urbich ◽

G Villa ◽

PS Farsky

Keyword(s):

Cardiovascular Risk ◽

Healthcare System ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

High Cardiovascular Risk ◽

Private Healthcare

Download Full-text

PDG23 Budget IMPACT Analysis of Eltrombopag Olamina for Immune Thrombocytopenia (ITP) in the Brazilian Private Healthcare System (BPHS)

Value in Health ◽

10.1016/j.jval.2020.08.706 ◽

2020 ◽

Vol 23 ◽

pp. S524

Author(s):

H. Kim ◽

G. Shamilian ◽

J.F. Bertinato

Keyword(s):

Healthcare System ◽

Immune Thrombocytopenia ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Private Healthcare

Download Full-text

PGI10 BUDGET IMPACT ANALYSIS OF INCORPORATING ENDOSCOPIC CAPSULE FOR DIAGNOSIS OF OBSCURE GASTROINTESTINAL BLEEDING IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

Value in Health ◽

10.1016/j.jval.2020.04.367 ◽

2020 ◽

Vol 23 ◽

pp. S144

Author(s):

A.M. Zuccaro ◽

F.A. Fujii ◽

P. Moretti

Keyword(s):

Gastrointestinal Bleeding ◽

Healthcare System ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Obscure Gastrointestinal Bleeding ◽

Private Healthcare ◽

Endoscopic Capsule

Download Full-text

PCN175 BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF MIDOSTAURIN FOR FLT3-POSITIVE ACUTE MYELOID LEUKEMIA (AML) IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM (BPHS).

Value in Health ◽

10.1016/j.jval.2019.09.371 ◽

2019 ◽

Vol 22 ◽

pp. S470

Author(s):

A. Buehler ◽

H.S.J. Kim ◽

L. Fahham ◽

A.L. Matsuo

Keyword(s):

Acute Myeloid Leukemia ◽

Healthcare System ◽

Myeloid Leukemia ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Private Healthcare ◽

Download Full-text

Budget Impact Analysis Of Tofacitinib For Rheumatoid Arthritis From The Perspective Of The Brazilian Private Healthcare System

Value in Health ◽

10.1016/j.jval.2015.09.2273 ◽

2015 ◽

Vol 18 (7) ◽

pp. A638

Author(s):

CN Ferreira ◽

CS Rufino ◽

CF Santana ◽

M Dulcine

Keyword(s):

Rheumatoid Arthritis ◽

Healthcare System ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Private Healthcare

Download Full-text

PCN101 Budget IMPACT Analysis of Treatment-Free Remission (TFR) of Nilotinib Therapy in Chronic Myeloid Leukemia (CML) Patients in the Brazilian Private Healthcare System (BPHS)

Value in Health ◽

10.1016/j.jval.2020.08.238 ◽

2020 ◽

Vol 23 ◽

pp. S440

Author(s):

H. Kim ◽

L. Fahham ◽

N.G.T.D.Q. Hazarbassanov ◽

D. Vivona

Keyword(s):

Chronic Myeloid Leukemia ◽

Healthcare System ◽

Myeloid Leukemia ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Private Healthcare ◽

Treatment Free Remission

Download Full-text

CP-041 New oral anticoagulants in non-valvular atrial fibrillation patients who are candidates for elective cardioversion: an example of budget impact analysis

10.1136/ejhpharm-2017-000640.40 ◽

2017 ◽

Author(s):

A Iezzi ◽

S Dellepiane ◽

E Omodeo Salè

Keyword(s):

Atrial Fibrillation ◽

Impact Analysis ◽

Budget Impact ◽

Oral Anticoagulants ◽

Budget Impact Analysis ◽

New Oral Anticoagulants

Download Full-text

Budget Impact Analysis Of Phased Radiofrequency (Rf) Catheter Ablation System In The Treatment Of Atrial Fibrillation (Af) In Turkey

Value in Health ◽

10.1016/j.jval.2015.09.626 ◽

2015 ◽

Vol 18 (7) ◽

pp. A348

Author(s):

AZ Ozdemir ◽

S Erdol ◽

H Can

Keyword(s):

Atrial Fibrillation ◽

Catheter Ablation ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Phased Radiofrequency

Download Full-text